Impairment Testing

October 29, 2018

Accounting Standards Update 2016-01: Impairment Considerations for Equity Investments

ASU 2016-01 shook up financial reporting at the beginning of the year, as companies scrambled to determine compliance with the new requirements for reporting equity investments.

The rise of corporate venture capital over recent years largely flew under the accounting radar until this update took effect, creating significant volatility for many corporate investors in their reported earnings as they were required to recognize the gains and losses from investments previously held at cost.

Now that the initial shock has worn off, CFOs may be able to rest a little easier, but they shouldn’t forget about the requirements under ASU 2016-01 entirely.

Even if the company elected the measurement alternative that allows for the investment to be reported at cost, don’t forget about the requirement for impairment testing that goes along with it. Some companies may choose to perform the initial Step Zero analysis internally before engaging a valuation firm to navigate the rest of the process, while others turn over the entire process to a valuation professional.

“An entity may elect to measure an equity security without a readily determinable fair value [and that does not qualify for the practical expedient]…at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.”

ASU 2016-01 Paragraph 321-10-35-2

Originally appeared in Mercer Capital's Financial Reporting Update: Goodwill Impairment

Continue Reading

The New Frontier Of Consumer Credit: Banks vs. Fintechs
The New Frontier Of Consumer Credit: Banks vs. Fintechs
Over the past three decades, community and regional banks have scaled back consumer lending while large banks and specialty finance companies have captured significant market share through economies of scale and robust origination platforms. Firms like American Express (NYSE:AXP), Capital One (NYSE:COF), Synchrony Financial (NYSE:SYF), and Ally Financial (NYSE:ALLY) leverage FDIC-insured deposit funding to power their lending operations. Most of these players, along with acquired entities like Discover Financial, operate at the intersection of payments and credit. Visa (NYSE:V) and Mastercard (NYSE:MC) are important payment partners to traditional banks, however.
Medical Device Industry Outlook – Five Long-Term Trends to Watch
Medical Device Industry Outlook – Five Long-Term Trends to Watch
Demographic shifts underlie the long-term market opportunity for medical device manufacturers. While efforts to control costs on the part of the government insurer in the U.S. (and elsewhere) may limit future pricing growth for incumbent products, a growing global market provides domestic device manufacturers with an opportunity to broaden and diversify their geographic revenue base. Developing new products and procedures is risky and usually more resource intensive compared to some other growth sectors of the economy. However, barriers to entry in the form of existing regulations provide a measure of relief from competition, especially for newly developed products.
A Decade in Motion: How COVID Reshaped Valuations in the Transportation Industry
A Decade in Motion: How COVID Reshaped Valuations in the Transportation Industry
The last several years have been nothing short of transformative for the transportation and logistics industry. Shifts in global trade patterns, consumer behavior, capital markets, and cost structures have left an indelible mark on both the operating performance and valuation metrics of transportation companies. A review of enterprise value to EBITDA (EV/ EBITDA) multiples across key subsectors, truckload, less-than-truckload (LTL), air, marine, rail, and logistics, reveals three distinct eras: the calm before the storm (pre-COVID), the whiplash of the pandemic years, and the normalization that followed.

Cart

Your cart is empty